US Stock MarketDetailed Quotes

BioXcel Therapeutics (BTAI)

Watchlist
  • 1.140
  • -0.070-5.79%
Close May 15 16:00 ET
  • 1.140
  • 0.0000.00%
Post 20:01 ET
30.87MMarket Cap-0.20P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioXcel Therapeutics (BTAI) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
20.01%-57.62M
4.04%-14.21M
-14.99%-18.79M
45.74%-12.58M
31.98%-12.04M
53.53%-72.03M
44.87%-14.81M
56.53%-16.34M
39.34%-23.17M
66.18%-17.71M
Net income from continuing operations
-17.28%-69.9M
-15.53%-12.55M
-126.45%-30.91M
-131.20%-19.19M
72.92%-7.25M
66.71%-59.6M
51.21%-10.86M
72.96%-13.65M
84.49%-8.3M
49.26%-26.79M
Operating gains losses
117.37%3.51M
44.96%-1.81M
360.29%12.54M
94.49%-663K
-21,763.33%-6.56M
-4,528.44%-20.18M
-2,601.64%-3.3M
-481,900.00%-4.82M
-2,104.40%-12.04M
-112.99%-30K
Depreciation and amortization
-2.91%300K
-3.90%74K
-2.60%75K
-2.60%75K
-2.56%76K
-2.83%309K
-1.28%77K
-2.53%77K
-4.94%77K
-2.50%78K
Other non cash items
1.31%7.41M
-81.71%553K
-65.39%523K
123.69%3.24M
132.16%3.1M
107.08%7.32M
191.23%3.02M
75.49%1.51M
73.83%1.45M
66.54%1.33M
Change In working capital
71.77%-1.7M
73.90%-928K
-20.63%-1.6M
144.36%2.41M
-137.07%-1.58M
-398.76%-6.03M
61.36%-3.56M
-116.65%-1.32M
-161.48%-5.42M
176.99%4.27M
-Change in receivables
-70.00%-102K
-82.03%-233K
-97.90%17K
96.08%-17K
142.67%131K
-133.90%-60K
-119.28%-128K
366.12%809K
-193.24%-434K
-777.14%-307K
-Change in inventory
-103.28%-43K
-131.09%-263K
-95.93%47K
156.43%136K
108.26%37K
21,966.67%1.31M
3,033.33%846K
1,341.94%1.16M
-992.59%-241K
-1,457.58%-448K
-Change in prepaid assets
-335.68%-8.16M
-876.49%-8.35M
67.10%-480K
114.16%65K
-32.52%608K
-164.82%-1.87M
-173.45%-855K
-164.82%-1.46M
-131.03%-459K
144.92%901K
-Change in payables and accrued expense
237.72%6.97M
340.60%8.01M
37.70%-1.08M
155.10%2.31M
-153.93%-2.27M
-601.25%-5.06M
69.65%-3.33M
-128.18%-1.74M
-155.72%-4.2M
221.55%4.21M
-Change in other current liabilities
-8.09%-374K
-7.95%-95K
-9.09%-96K
-6.90%-93K
-8.43%-90K
-8.46%-346K
-7.32%-88K
-8.64%-88K
-10.13%-87K
-7.79%-83K
Cash from discontinued investing activities
Operating cash flow
20.01%-57.62M
4.04%-14.21M
-14.99%-18.79M
45.74%-12.58M
31.98%-12.04M
53.53%-72.03M
44.87%-14.81M
56.53%-16.34M
39.34%-23.17M
66.18%-17.71M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
0
0
0
0
0
Net PPE purchase and sale
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
54.17%56.52M
32.06%5.65M
8,166.96%37.53M
-97.42%137K
-50.42%13.2M
38.22%36.66M
101.41%4.28M
454K
2,021.60%5.3M
10.26%26.63M
Net issuance payments of debt
--0
----
----
----
----
---2.5M
----
----
----
----
Net common stock issuance
46.50%58.14M
-17.70%5.76M
8,069.66%38.23M
-97.44%140K
-47.63%14.01M
46.82%39.69M
194.78%7M
--468K
--5.48M
8.46%26.74M
Proceeds from stock option exercised by employees
----
----
----
----
----
--0
--0
--0
--0
--0
Net other financing activities
-207.58%-1.62M
48.89%-115K
-4,914.29%-702K
98.26%-3K
-587.18%-804K
48.13%-528K
10.71%-225K
---14K
---172K
84.73%-117K
Cash from discontinued financing activities
Financing cash flow
54.17%56.52M
32.06%5.65M
8,166.96%37.53M
-97.42%137K
-50.42%13.2M
38.22%36.66M
101.41%4.28M
--454K
2,021.60%5.3M
10.26%26.63M
Net cash flow
Beginning cash position
-54.23%29.85M
-7.59%37.32M
-66.99%18.58M
-58.17%31.01M
-54.23%29.85M
-66.33%65.22M
-55.11%40.39M
-55.88%56.27M
-55.21%74.14M
-66.33%65.22M
Current changes in cash
96.90%-1.1M
18.70%-8.56M
218.01%18.75M
30.40%-12.44M
-87.01%1.16M
72.48%-35.37M
57.43%-10.53M
57.74%-15.88M
52.94%-17.87M
131.63%8.92M
End cash Position
-3.67%28.76M
-3.67%28.76M
-7.59%37.32M
-66.99%18.58M
-58.17%31.01M
-54.23%29.85M
-54.23%29.85M
-55.11%40.39M
-55.88%56.27M
-55.21%74.14M
Free cash flow
20.01%-57.62M
4.04%-14.21M
-14.99%-18.79M
45.74%-12.58M
31.98%-12.04M
53.54%-72.03M
44.87%-14.81M
56.53%-16.34M
39.38%-23.17M
66.18%-17.71M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 20.01%-57.62M4.04%-14.21M-14.99%-18.79M45.74%-12.58M31.98%-12.04M53.53%-72.03M44.87%-14.81M56.53%-16.34M39.34%-23.17M66.18%-17.71M
Net income from continuing operations -17.28%-69.9M-15.53%-12.55M-126.45%-30.91M-131.20%-19.19M72.92%-7.25M66.71%-59.6M51.21%-10.86M72.96%-13.65M84.49%-8.3M49.26%-26.79M
Operating gains losses 117.37%3.51M44.96%-1.81M360.29%12.54M94.49%-663K-21,763.33%-6.56M-4,528.44%-20.18M-2,601.64%-3.3M-481,900.00%-4.82M-2,104.40%-12.04M-112.99%-30K
Depreciation and amortization -2.91%300K-3.90%74K-2.60%75K-2.60%75K-2.56%76K-2.83%309K-1.28%77K-2.53%77K-4.94%77K-2.50%78K
Other non cash items 1.31%7.41M-81.71%553K-65.39%523K123.69%3.24M132.16%3.1M107.08%7.32M191.23%3.02M75.49%1.51M73.83%1.45M66.54%1.33M
Change In working capital 71.77%-1.7M73.90%-928K-20.63%-1.6M144.36%2.41M-137.07%-1.58M-398.76%-6.03M61.36%-3.56M-116.65%-1.32M-161.48%-5.42M176.99%4.27M
-Change in receivables -70.00%-102K-82.03%-233K-97.90%17K96.08%-17K142.67%131K-133.90%-60K-119.28%-128K366.12%809K-193.24%-434K-777.14%-307K
-Change in inventory -103.28%-43K-131.09%-263K-95.93%47K156.43%136K108.26%37K21,966.67%1.31M3,033.33%846K1,341.94%1.16M-992.59%-241K-1,457.58%-448K
-Change in prepaid assets -335.68%-8.16M-876.49%-8.35M67.10%-480K114.16%65K-32.52%608K-164.82%-1.87M-173.45%-855K-164.82%-1.46M-131.03%-459K144.92%901K
-Change in payables and accrued expense 237.72%6.97M340.60%8.01M37.70%-1.08M155.10%2.31M-153.93%-2.27M-601.25%-5.06M69.65%-3.33M-128.18%-1.74M-155.72%-4.2M221.55%4.21M
-Change in other current liabilities -8.09%-374K-7.95%-95K-9.09%-96K-6.90%-93K-8.43%-90K-8.46%-346K-7.32%-88K-8.64%-88K-10.13%-87K-7.79%-83K
Cash from discontinued investing activities
Operating cash flow 20.01%-57.62M4.04%-14.21M-14.99%-18.79M45.74%-12.58M31.98%-12.04M53.53%-72.03M44.87%-14.81M56.53%-16.34M39.34%-23.17M66.18%-17.71M
Investing cash flow
Cash flow from continuing investing activities 0000000000
Net PPE purchase and sale --0--0--0--0--0--0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 54.17%56.52M32.06%5.65M8,166.96%37.53M-97.42%137K-50.42%13.2M38.22%36.66M101.41%4.28M454K2,021.60%5.3M10.26%26.63M
Net issuance payments of debt --0-------------------2.5M----------------
Net common stock issuance 46.50%58.14M-17.70%5.76M8,069.66%38.23M-97.44%140K-47.63%14.01M46.82%39.69M194.78%7M--468K--5.48M8.46%26.74M
Proceeds from stock option exercised by employees ----------------------0--0--0--0--0
Net other financing activities -207.58%-1.62M48.89%-115K-4,914.29%-702K98.26%-3K-587.18%-804K48.13%-528K10.71%-225K---14K---172K84.73%-117K
Cash from discontinued financing activities
Financing cash flow 54.17%56.52M32.06%5.65M8,166.96%37.53M-97.42%137K-50.42%13.2M38.22%36.66M101.41%4.28M--454K2,021.60%5.3M10.26%26.63M
Net cash flow
Beginning cash position -54.23%29.85M-7.59%37.32M-66.99%18.58M-58.17%31.01M-54.23%29.85M-66.33%65.22M-55.11%40.39M-55.88%56.27M-55.21%74.14M-66.33%65.22M
Current changes in cash 96.90%-1.1M18.70%-8.56M218.01%18.75M30.40%-12.44M-87.01%1.16M72.48%-35.37M57.43%-10.53M57.74%-15.88M52.94%-17.87M131.63%8.92M
End cash Position -3.67%28.76M-3.67%28.76M-7.59%37.32M-66.99%18.58M-58.17%31.01M-54.23%29.85M-54.23%29.85M-55.11%40.39M-55.88%56.27M-55.21%74.14M
Free cash flow 20.01%-57.62M4.04%-14.21M-14.99%-18.79M45.74%-12.58M31.98%-12.04M53.54%-72.03M44.87%-14.81M56.53%-16.34M39.38%-23.17M66.18%-17.71M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -